Find Academic Supervisors

Laurie FordView profile

Associate Professor

• Family-School-Community Partnerships and Relationships
• Early Childhood Mental Health
• Assessment with Young Children
• +7 more

Laurie Ford is an Associate Professor at the University of British Columbia , affiliated with the Faculty of Education and the Department of Educational and Counselling Psychology, and Special Education . She serves as the SACP Admissions Coordinator , Director of Training , and Director of Early Childhood Education . Her work bridges Child and Adolescent Development with Family-School-Community Partnerships , emphasizing culturally responsive practices. Dr. Ford’s research focuses on Early Childhood Assessment , Multi-disciplinary Teams , and Supporting Vulnerable Populations , including immigrants, refugees, and children with chronic health conditions like IBD. She leads the Children, Families, and Communities Lab , where students explore topics such as Cognitive Assessment , Family Engagement , and Community-level Child Development . Her recent publications analyze psychometric tools in diverse populations, assessment feedback communication, and community factors influencing child development. She has presented nationally and internationally on topics like Indigenous Family Engagement and School Belonging for Refugee Students . Dr. Ford has supervised over 75 graduate theses and collaborates with global institutions, including the University of Melbourne on the KIDS in Communities Study (KICS) . Current projects examine school belonging for immigrant/refugee families , supporting children with inflammatory bowel disease , and cross-national assessment norms . She advocates for collaborative approaches to address Early Childhood Mental Health and Multi-cultural Considerations in educational environments.

• Maternal and Child Health
• Reproductive Health
• Public Health
• +3 more

K.S. Joseph is a Professor in the Department of Obstetrics & Gynaecology at the University of British Columbia, Faculty of Medicine, and an active staff member at BC Women's Hospital. He is affiliated with the BC Children's Hospital Research Institute and contributes to the department's Maternal Fetal Medicine and Reproductive Endocrinology & Infertility divisions. His research focuses on maternal and child health outcomes, reproductive epidemiology, and population health sciences. Key areas include: Women's and Children's Health Sciences Reproductive and Developmental Sciences Population and Public Health Dr. Joseph supervises graduate students in thesis-based programs including Master of Science and Doctor of Philosophy degrees in Population and Public Health and Women+ and Children's Health Sciences, as well as the dual Master of Public Health and Master of Science in Nursing program. He maintains active involvement in the department's educational initiatives and research supervision within UBC's Graduate and Postdoctoral Studies framework, with program affiliations spanning Reproductive and Developmental Sciences, Population and Public Health, and Women+ and Children's Health Sciences.

Min XuView profile

Professor

• Biomedical Image Analysis
• Computer Vision
• Machine Learning
• +4 more

Dr. Min Xu is a Courtesy Professor in the Computational Biology Department within the School of Computer Science at Carnegie Mellon University. His research focuses on advancing computer vision and machine learning for biomedical image analysis, particularly cellular cryo-electron tomography (Cryo-ET) and automated science video analysis. He leads a lab developing cutting-edge computational tools for structural biology and medical imaging. Key research directions include: High-resolution 3D Cryo-ET image analysis AI-driven medical image segmentation Few-shot learning for cryo-EM analysis Video analysis frameworks for laboratory automation Notable contributions include the AITom toolkit for Cryo-ET analysis and pioneering work in adapting foundation models for medical imaging tasks. His work has been published in top venues like CVPR, MICCAI, and Nature-associated journals. No academic awards or grants are explicitly listed in the provided text. He maintains an active lab focused on translating computational methods into impactful biomedical research tools.

• Neonatology
• Pediatrics
• Body Composition
• +5 more

Overview Catherine O'Neill Buck is an Assistant Professor in the Department of Pediatrics, Division of Neonatal-Perinatal Medicine at Yale School of Medicine. She is a neonatologist and clinical researcher focused on maternal metabolic health during pregnancy and its influence on infant growth, body composition, and neurodevelopment. Her work bridges clinical care and translational research, with a particular emphasis on preterm infants and obesity prevention. Education & Training MD: University of Connecticut School of Medicine BS: University of Connecticut (Molecular/Cell Biology and Spanish) Pediatric Residency: University of Texas Southwestern Medical School (2015) Neonatal-Perinatal Medicine Fellowship: Brown University/Women and Infants Hospital (2019) MHS (Clinical Investigation): Yale School of Medicine (2025) Research Focus Dr. Buck's research investigates how maternal metabolic conditions (e.g., diabetes) and early neonatal nutrition affect preterm and term infants' growth trajectories, adiposity, and long-term cardiometabolic health. Key areas include: Adipokine and metabolite profiling in newborns Ultrasound-based body composition assessment in preterm infants Optimizing nutritional protocols for preterm growth Impact of maternal diabetes on neonatal morbidities Clinical Trial Principal Investigator for the trial Preventing Obesity in Preterm Infants (HIC ID 2000031084), exploring strategies to mitigate obesity risks in preterm populations. Labs/Teams Leads the Yale Neonatal NOuRISH Team , focusing on nutritional and metabolic interventions for neonates.

Brent FogelView profile

Professor

• Neurogenetics
• Hereditary Ataxia
• Spinocerebellar Ataxia
• +7 more

Dr. Brent Fogel is a Professor in the Departments of Neurology and Human Genetics at the David Geffen School of Medicine, UCLA. He directs the Neurogenetics Clinic and the UCLA Clinical Neurogenomics Research Center , focusing on diagnosing and managing genetic neurological disorders such as cerebellar ataxia , ataxia with oculomotor apraxia , spastic paraplegia , and leukodystrophies . His research integrates genomics , bioinformatics , and neuroimaging to improve precision medicine in prenatal counseling and rare disease diagnosis. Education: MD, PhD from Medical College of Wisconsin (2003) PhD in Genetics (2001) Internship in Internal Medicine (Northwestern University, 2004) Residency in Neurology (UCLA, 2007) Fellowship in Neurogenetics (UCLA, 2009) Board Certified in Neurology (2009) Research Focus: Dr. Fogel’s work spans neurogenetics , spinocerebellar ataxia , leukodystrophy , and genomic technologies . He has pioneered gene discovery in hereditary ataxias, developed transcriptional biomarkers , and contributed to diagnostic guidelines for rare disorders. His studies on lysosomal genes in Parkinson’s disease and exome sequencing disparities address critical gaps in neurogenetic research. Key Collaborations: He leads multicenter studies with the Ataxia Global Initiative , Undiagnosed Diseases Network , and Genomics England Research Consortium . His lab ( FogelLab ) develops tools like multiWGCNA for gene network analysis.

• Animal Biotechnology
• Molecular Biology
• In-Vitro Cell Culture
• +5 more

Mahipal Singh is a Professor of Animal Biotechnology and Coordinator of the Animal Science Undergraduate Program at Fort Valley State University (FVSU), where he is affiliated with the College of Agriculture, Family Sciences and Technology and the Department of Agricultural Sciences. He has been at FVSU since 2000 in various capacities, progressing from Adjunct Biology/MPH Graduate Faculty to his current position as full Professor since 2019. Dr. Singh earned his educational credentials in India: a B.S. (Hons) in Zoology from Meerut College (1978), an M.S. in Zoology from the Institute of Advanced Studies, Meerut University (1983), and a Ph.D. in Zoology-Microbiology from Banaras Hindu University, Varanasi (1989). His academic journey included prestigious appointments such as International Visiting Fellow at the National Institute of Child Health and Human Development, NIH (1991-1993) and Postdoctoral Fellow at the Medical University of South Carolina (1989-1991). His research focuses on cutting-edge areas of animal biotechnology, particularly in postmortem cell recovery, genome editing in livestock, and myostatin gene targeting. Dr. Singh has pioneered work demonstrating that individual cells remain viable in mammalian tissues for much longer periods after death than previously believed, with applications for cellular therapies and germplasm preservation. His work with CRISPR/Cas technology aims to reduce milk allergens and mastitis in goats, while his myostatin research seeks to enhance muscular mass in meat goats for agricultural applications. Analysis of his recent publications reveals a consistent focus on cellular viability after death across multiple livestock species (cattle, goats, sheep), with particular attention to temperature effects and storage conditions. His work bridges basic cellular biology with practical agricultural applications, demonstrating how fundamental discoveries about postmortem cellular life can translate into biotechnological advances for livestock preservation and improvement. USDA-ARS 1890 Faculty Research Fellowship Award (2017) STEM Research Excellence Award, Fort Valley State University (2014-15) Multiple student research presentation awards at FVSU Annual Research Day symposiums Best Poster Award at National Symposium on Biotechnology, CIMAP, Lucknow, India (1999) Fogarty International Visiting Fellowship at NIH (1991-93) Dr. Singh has supervised an impressive 38 students across multiple educational levels, including 4 PhD, 13 MS, 7 BS, 8 HS, and 6 middle school students. His research has been supported by USDA-ARS, USDA-NIFA programs, and various other grants. He serves on multiple editorial boards, grant review panels, and university committees, and is an active member of professional societies including the American Society of Animal Science and Society for In Vitro Biology. Based in the Stallworth Biotechnology Building at FVSU, Dr. Singh leads research projects that bridge molecular biology with practical agricultural applications, working collaboratively with researchers from USDA-ARS, University of Illinois, University of Maryland, and other institutions to advance animal biotechnology and improve livestock production systems.

• Skeletal Muscle Physiology
• Mitochondrial Biology
• Metabolic Disease
• +3 more

Dr. Nicholas Broskey is an Associate Professor in the Department of Kinesiology at the College of Health and Human Performance, East Carolina University. His research bridges translational science and clinical practice, focusing on skeletal muscle physiology and mitochondrial biology to address metabolic diseases through exercise interventions. Dr. Broskey's work explores how maternal health during pregnancy programs infants' metabolic health outcomes, utilizing mesenchymal stem cell models to study developmental programming of obesity and diabetes. He combines clinical expertise in exercise prescription and metabolic assessment (e.g., hyperinsulinemic-euglycemic clamp, indirect calorimetry) with basic science techniques to evaluate mitochondrial content and function. His recent publications highlight maternal exercise effects on offspring metabolism, mitochondrial heterogeneity in racial health disparities, and bioenergetic adaptations in cancer cells. Grants from NIH, Brody Brothers' Foundation, and Duke University support his research on maternal-fetal metabolic programming and exercise transducers. Scientific Awards Outstanding Researcher or Creative Activity Award 2023-2024 Early Career Grant Challenge 2018 Endowed Postdoctoral Fellowship 2015 Best Poster 2012 Dr. Broskey actively serves on editorial boards for Clinical Experimental Obstetrics and Gynecology (2023) and International Journal of Sports Medicine (2022).

• Neonatal Neurology
• Brain Development
• Preterm Infant Brain Injury
• +5 more

Dr. Steven P. Miller is a Professor and Head of the Department of Pediatrics at the University of British Columbia's Faculty of Medicine. He also serves as the Chief of Pediatric Medicine at BC Children's Hospital & Sunny Hill Health Centre under the Provincial Health Services Authority. Additionally, he holds the Hudson Family Hospital Chair in Pediatric Medicine and is an Investigator at BC Children's Hospital. Dr. Miller's research focuses on neonatal neurology, particularly brain development and injury in newborns. His work utilizes advanced magnetic resonance techniques and bedside brain monitoring to understand how a baby's critical care experience influences their risk of brain injury and developmental trajectory. His research areas include birth defects, concussion, preterm labor, and steroid effects on neonatal brain development. Analysis of Dr. Miller's recent publications reveals a strong emphasis on understanding the relationship between neonatal pain exposure, analgesia, and brain development in preterm infants. His work also extensively examines neurodevelopmental outcomes in infants with congenital heart disease, exploring how fetal hemodynamics, surgical interventions, and brain imaging findings correlate with long-term cognitive outcomes. A significant portion of his research investigates the impact of socioeconomic status on brain development and neurocognitive outcomes in preterm infants. Dr. Miller is actively involved in graduate education, supervising students in Neuroscience and Women+ and Children's Health Sciences programs at UBC. His research group, part of the Brain, Behaviour & Development Research Theme and the Neurodevelopmental and Neurological Disorders Visualizing the Brain Research Group, has published extensively in top-tier journals across neurology, pediatrics, and neuroscience.

Brandon K. HadlandView profile

Associate Professor

• Hematopoietic stem cell development
• Notch signaling
• Hematopoietic niche
• +5 more

Dr. Brandon K. Hadland is an Associate Professor at the University of Washington School of Medicine in Pediatrics and Fred Hutchinson Cancer Center's Translational Science and Therapeutics Division, with memberships in the Immunotherapy and Translational Data Science Integrated Research Centers. He serves as an Attending Physician at Seattle Children's Hospital for Pediatric Hematology/Oncology and Bone Marrow Transplant. Education: BS in Chemistry, Harvey Mudd College (1998) MD and PhD in Molecular Cell Biology, Washington University School of Medicine (2006) Pediatrics Residency and Internship, Seattle Children's/University of Washington (2006-2009) Pediatric Hematology/Oncology Fellowship, Seattle Children's/University of Washington/Fred Hutch (2009-2012) His research centers on embryonic hematopoietic stem cell (HSC) development, investigating Notch signaling pathways, vascular microenvironments in the AGM region and fetal liver, and engineering in vitro platforms to model blood formation. He employs single-cell functional and molecular techniques to characterize niche interactions and transcriptional programs driving HSC emergence. Recent publications demonstrate trends in applying single-cell transcriptomics to define HSC-competent hemogenic endothelium and develop stromal-free engineered niches, bridging developmental biology with therapeutic applications for blood disorders and leukemia. Dr. Hadland leads collaborative research across Fred Hutch and UW, partnering with experts in computational genomics (Dr. Cole Trapnell), stem cell engineering (Drs. Sergei Doulatov and Ying Zheng), and pediatric oncology (Drs. Soheil Meshinchi and Irv Bernstein) to advance cellular therapies and leukemia prevention strategies.

Matti SällbergView profile

Professor

• Virology
• Immunology
• Vaccine Development
• +4 more

Matti Sällberg is a Professor in Biomedical Analysis at Karolinska Institutet's Department of Laboratory Medicine, leading the VIVAC research group focused on vaccines and immunotherapies against viruses and cancer. He earned his DDS and PhD from Karolinska Institutet (1988-1992), followed by postdoctoral research at The Scripps Research Institute (1994-1996). As a leader in infectious disease and hepatology, his research addresses chronic viral hepatitis, cancer prevention, and gene/cell-based therapies (GTMPs/ATMPs). He has directed the Department of Laboratory Medicine (2011-2022) and actively teaches in biomedical laboratory science, dentistry, medicine, and nursing programs. Key research areas include SARS-CoV-2 vaccine development (OPENCORONA consortium), hepatitis B/D/C therapies, and Crimean-Congo hemorrhagic fever vaccines. His work combines basic science with translational efforts at Karolinska's ANA Futura facility. Notable projects include a phase I clinical trial for a broad-acting SARS-CoV vaccine and preclinical testing of hepatitis therapies. Collaborations span academia and industry, with funding from the Swedish Cancer Society, EU, and VINNOVA. He oversees advanced techniques like viral propagation, flow cytometry, and adoptive cell therapy manufacturing. Grants include a 2024 Swedish Cancer Society award for hepatitis-related cancer therapies and a 2022 Swedish Research Council grant for the Doctoral Program in Advanced Therapies. His team maintains an active lab with researchers like Lars Frelin and Gustaf Ahlén. Future work emphasizes expanding vaccine platforms against emerging pathogens and optimizing immuno-therapies for solid tumors.

Michelle LamplView profile

Professor

• Biological Anthropology
• Human Growth and Development
• Nutrition Science
• +3 more

Dr. Michelle Lampl is the Charles Howard Candler Professor at Emory University and Director of the Emory Center for the Study of Human Health. She holds leadership roles in the Emory-Georgia Tech Predictive Health Initiative and the Center for Health Discovery & Well Being. Her academic career spans over three decades, with a focus on human growth and development from an interdisciplinary perspective. Dr. Lampl earned her PhD (1983) and MD (1989) from the University of Pennsylvania. Her research revolutionized understanding of growth patterns through her discovery of saltatory growth (spurt-based growth cycles). Current studies investigate genetic/environmental interactions influencing growth, including hormonal, nutritional, and immunological networks. Her research portfolio includes collaborations with international institutions like the University of Southampton (UK) and NIH-funded projects through NICHD. Over 100 peer-reviewed publications highlight her contributions to developmental origins of health and disease (DOHaD), fetal programming, and pediatric growth mechanisms. Dr. Lampl pioneered the undergraduate College programs in human health and co-developed Emory’s Predictive Health strategic plan. She launched the Predictive Health & Society minor and contributes to the Molecules to Mankind graduate program. Her awards include AAAS Fellowship (2010) and Emory’s top teaching honor. Key areas of impact: Established growth chart limitations through saltation theory Linked maternal nutrition to fetal growth trajectories Advocated for interdisciplinary health education

• Autism Spectrum Disorders
• Child Psychiatry
• Developmental Disabilities
• +8 more

Katarzyna Chawarska is the Emily Fraser Beede Professor of Child Psychiatry at Yale School of Medicine, with primary affiliation in the Child Study Center and secondary appointments in Pediatrics and Statistics. She is a leading expert in autism spectrum disorders (ASD), directing the NIH Autism Center of Excellence, the Social and Affective Neuroscience of Autism Program, and the Yale Toddler Developmental Disabilities Clinic. Education: PhD in Psychology, Yale University (2000) Post-Doctoral Fellowship, Yale University School of Medicine (2000) MS in Psychology, Yale University MPhil in Psychology, Yale University MA, Jagiellonian University (1986) Her research focuses on identifying early diagnostic markers and novel treatment targets in ASD, particularly in infants at risk due to familial, genetic, or perinatal factors. Her work integrates clinical assessment, neuroimaging, eye-tracking, and longitudinal design to understand the neurodevelopmental trajectories of autism. Her recent publications explore disrupted functional connectivity, atypical visual attention, social anhedonia, and familial recurrence in autism. She employs advanced methodologies including fMRI, eye movement dynamics, and machine learning to identify biomarkers. Her research spans developmental neuroscience, clinical psychology, genetics, and pediatric psychiatry, with strong emphasis on early detection and intervention. Scientific Awards: No specific awards mentioned in the provided text. Dr. Chawarska is the Principal Investigator on active clinical trials, including studies on emotional development in infants at risk for ASD and regulation of visual attention and emotion in autism. She mentors research through her lab and collaborates extensively with experts such as Fred Volkmar, James McPartland, and Frederick Shic. She leads the Chawarska Lab, which is part of the Center for Brain & Mind Health and the Wu Tsai Institute at Yale.

Jessie P. BuckleyView profile

Associate Professor

• Environmental Toxicants
• Exposure Assessment
• Exposure Mixtures
• +3 more

Jessie P. Buckley, PhD, MPH is an Associate Professor in the Department of Epidemiology at the University of North Carolina Gillings School of Global Public Health. She serves as Director of Chemical Exposure Methodology for the NIH Environmental influences on Child Health Outcomes (ECHO) Program, focusing on data harmonization and pooled analyses of chemical exposures in children's health. Education: PhD in Epidemiology (UNC Chapel Hill, 2014) MPH in Environmental and Occupational Health (George Washington University, 2007) AB in Biology and English (Bowdoin College, 2002) Her research investigates environmental toxicants' health effects, particularly: Exposure assessment of environmental chemicals Methods for estimating effects of exposure mixtures Environmental influences on cardiometabolic and bone health Endocrine-disrupting chemicals Children's environmental health Recent publications analyze: PFAS exposure trends in adolescent bone health Chemical mixture effects using item response theory Perinatal exposure to melamine analogues Diet-exposure interactions in ultra-processed foods Scientific Awards: Teaching Innovation Award (UNC Gillings, 2025) NIEHS ONES Award (2019) Pediatric Loan Repayment Program Awards (2020, 2022, 2023) Dr. Buckley contributes to academic service as: Member of the PhD Admissions Committee (2024-present) Co-Chair of the North America Chapter, International Society of Environmental Epidemiology (2023-present)

Arpan A. PatelView profile

Associate Professor

• Thoracic Oncology
• Lung Cancer
• Head and Neck Cancer
• +4 more

Arpan A. Patel, M.D. serves as Associate Professor in the Department of Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. Board-certified in Hematology, Internal Medicine, and Medical Oncology, he specializes in lung cancer (including small cell, non-small cell lung cancer, and mesothelioma) and head and neck cancer through UR Medicine's comprehensive cancer program. His educational foundation includes: MD from Medical University of Lublin (Poland), 2012 Internal Medicine Residency at SUNY Upstate University Hospital, 2013-2016 Hematology & Oncology Fellowship at University of Florida College of Medicine, 2016-2019 Dr. Patel's research examines thoracic oncology, quality improvement, financial toxicity, patient distress, and medical education. His clinical philosophy emphasizes compassionate, patient-centered care addressing financial burdens and quality-of-life concerns through multidisciplinary teamwork. He actively conducts clinical trials to advance lung cancer treatment while documenting patient distress in veteran populations. His scholarly output reveals consistent focus on hematologic disorders, oncology documentation, and medical education innovation. Publications demonstrate expertise in rare hematologic conditions (HLH, PNH), anticoagulant management, and curriculum development for resident training - reflecting dual clinical strengths in hematology and oncology. Recognition includes: Chief Fellow Award and Craig S Kitchens Award for Mentorship (2019) Gold Humanism Honor Society inductions (2018, 2012) Multiple teaching excellence awards (2015, 2012) Quality improvement honors (2018, 2015) As an educator, he develops innovative curricula for oncologic documentation while mentoring residents. His work bridges clinical practice and scholarly inquiry through the University of Rochester's academic medical center. Dr. Patel collaborates within multidisciplinary oncology teams to deliver comprehensive cancer care through Accountable Health Partners network.

Juan BaezaView profile

Senior Lecturer

• Health Policy
• Professional Relations
• Healthcare Reform
• +3 more

Juan Baeza is a Senior Lecturer in Health Policy at King's Business School, King's College London. He holds a PhD from the University of Kent, an MSc from the London School of Economics, and a BA from Goldsmiths, University of London. His research focuses on health policy analysis, particularly examining the impact of health reforms on medical professions and health systems globally, with a focus on the UK's NHS, as well as Chile, Mexico, Russia, Sweden, Poland, and Australia. Affiliations: King's Business School, Department of Public Services Management and Organisation. Education: PhD in Health Policy (University of Kent, 2002), MSc in Economics (LSE, 1993), BA in Social Sciences (Goldsmiths, 1990). Research Interests: Baeza's work explores professional relations within healthcare, healthcare reform, evidence-based practice, and organizational change. He emphasizes how health policies are translated into actionable practices by healthcare professionals and how medical professions influence policy development and implementation. Recent Articles Trends: His publications highlight themes such as integrated care collaboration, the role of evidence in healthcare decision-making, and the governance of pluralist healthcare systems. Recent work includes analyses of pandemic discourse (e.g., Brazil's response to COVID-19) and the reconfiguration of health services in England. Grants & Projects: Co-investigator in projects like the AI-assisted fetal ultrasound trial (NIHR-funded) and studies on stroke care implementation across Europe. Teaching & Leadership: Teaches health policy modules, directs the intercalated BSc in Healthcare Management, and leads executive education programs. Labs/Teams: Active in the Integrated Care Systems (ICS) Research-Practice Network, organizing workshops on healthcare collaboration and prevention strategies.